Aethlon Medical Inc

Medical Devices

Prices are adjusted according to historical splits.

Aethlon Medical Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$11.24 million
Book Value:
Revenue TTM:
Operating Margin TTM:
Gross Profit TTM:
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Aethlon Medical Inc had its IPO on 2001-01-02 under the ticker symbol AEMD.

The company operates in the Healthcare sector and Medical Devices industry. Aethlon Medical Inc has a staff strength of 14 employees.

Stock update

Shares of Aethlon Medical Inc opened at $0.42 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $0.38 - $0.42, and closed at $0.39.

This is a -4.88% slip from the previous day's closing price.

A total volume of 203,600 shares were traded at the close of the day’s session.

In the last one week, shares of Aethlon Medical Inc have slipped by -11.36%.

Aethlon Medical Inc's Key Ratios

Aethlon Medical Inc has a market cap of $11.24 million, indicating a price to book ratio of 0.4273 and a price to sales ratio of 228.4526.

In the last 12-months Aethlon Medical Inc’s revenue was $13116 with a gross profit of $294165 and an EBITDA of $-13019756. The EBITDA ratio measures Aethlon Medical Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Aethlon Medical Inc’s operating margin was -100689.45% while its return on assets stood at -38.71% with a return of equity of -70.56%.

In Q4, Aethlon Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 61.7%.

Aethlon Medical Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-0.72 per share while it has a forward price to earnings multiple of 0.2102 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Aethlon Medical Inc’s profitability.

Aethlon Medical Inc stock is trading at a EV to sales ratio of 1.0661 and a EV to EBITDA ratio of 0.7672. Its price to sales ratio in the trailing 12-months stood at 228.4526.

Aethlon Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$20.72 million
Total Liabilities
$2.44 million
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Aethlon Medical Inc ended 2023 with $20.72 million in total assets and $0 in total liabilities. Its intangible assets were valued at $20.72 million while shareholder equity stood at $17.28 million.

Aethlon Medical Inc ended 2023 with $0 in deferred long-term liabilities, $2.44 million in other current liabilities, 22971.00 in common stock, $-139892032.00 in retained earnings and $0 in goodwill. Its cash balance stood at $17.50 million and cash and short-term investments were $17.50 million. The company’s total short-term debt was $264,278 while long-term debt stood at $0.

Aethlon Medical Inc’s total current assets stands at $18.17 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0.00 compared to accounts payable of $226791.00 and inventory worth $0.

In 2023, Aethlon Medical Inc's operating cash flow was $0 while its capital expenditure stood at $931039.67.

Comparatively, Aethlon Medical Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Aethlon Medical Inc stock is currently trading at $0.39 per share. It touched a 52-week high of $2.46 and a 52-week low of $2.46. Analysts tracking the stock have a 12-month average target price of $7.38.

Its 50-day moving average was $0.5 and 200-day moving average was $0.73 The short ratio stood at 0.09 indicating a short percent outstanding of 0%.

Around 106.5% of the company’s stock are held by insiders while 581% are held by institutions.

Frequently Asked Questions About Aethlon Medical Inc

The stock symbol (also called stock or share ticker) of Aethlon Medical Inc is AEMD

The IPO of Aethlon Medical Inc took place on 2001-01-02

Similar Industry Stocks (Medical Devices)

Last Price
Mene Inc (MENEF)

Most Active

Last Price

Top Gainers

Last Price

Top Losers

Last Price


Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.


11555 Sorrento Valley Road, San Diego, CA, United States, 92121